Molecular and histological evaluation of pancreata from patients with a mitochondrial gene mutation associated with impaired insulin secretion.

A mutation in mitochondrial DNA, which was originally identified in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), can be associated with a subtype of diabetes mellitus. To determine the molecular and histological basis of impaired insulin secretion in the subjects with this mutation, we studied autopsy pancreata specimens from eight subjects diagnosed as having MELAS. The 3243 bp mutation was identified in seven out of eight pancreata examined. Immunohistochemical studies demonstrated a reduction in total islet mass, and in the numbers of both B and A cells. No evidence of insulitis or apoptosis was found. These data suggested that the 3243 bp mutation may cause the reduction of islet cells, mainly through mechanisms other than autoimmune destruction.

[1]  Y. Yazaki,et al.  Ethidium Bromide-induced Inhibition of Mitochondrial Gene Transcription Suppresses Glucose-stimulated Insulin Release in the Mouse Pancreatic β-Cell Line βHC9* , 1998, The Journal of Biological Chemistry.

[2]  T. Kobayashi,et al.  In Situ Characterization of Islets in Diabetes With a Mitochondrial DNA Mutation at Nucleotide Position 3243 , 1997, Diabetes.

[3]  M. Kojiro,et al.  Apoptosis in the Pancreas of Genetically Diabetic Rats with a Disrupted Cholecystokinin (CCK‐A) Receptor Gene , 1997, Pancreas.

[4]  P. Froguel,et al.  Clinical Phenotypes, Insulin Secretion, and Insulin Sensitivity in Kindreds With Maternally Inherited Diabetes and Deafness Due to Mitochondrial tRNALeu(UUR) Gene Mutation , 1996, Diabetes.

[5]  Y. Yazaki,et al.  The high prevalence of the diabetic patients with a mutation in the mitochondrial gene in Japan. , 1994, The Journal of clinical endocrinology and metabolism.

[6]  P. Froguel,et al.  Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA Leu(UUR) gene , 1994, Diabetes.

[7]  R. Sakuta,et al.  A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. , 1994, The New England journal of medicine.

[8]  P. Froguel,et al.  Prevalence of mitochondrial gene mutations in families with diabetes mellitus , 1993, The Lancet.

[9]  Y. Yazaki,et al.  Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics , 1993, The Lancet.

[10]  J. Dichgans,et al.  Mitochondrial gene mutations and diabetes mellitus , 1993, The Lancet.

[11]  M. Pembrey,et al.  Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA , 1992, The Lancet.

[12]  J. Maassen,et al.  Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.

[13]  D. Wallace,et al.  Diseases of the mitochondrial DNA. , 1992, Annual review of biochemistry.

[14]  E. Kaplan,et al.  N-ras 61 oncogene mutations in Hürthle cell tumors. , 1990, Surgery.

[15]  D. Wallace,et al.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation , 1990, Cell.

[16]  F M Matschinsky,et al.  Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and Hepatocytes , 1990, Diabetes.

[17]  J. Leahy,et al.  Compensatory Growth of Pancreatic β-Cells in Adult Rats After Short-Term Glucose Infusion , 1989, Diabetes.

[18]  B. Vogelstein,et al.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. , 1985, Biochemical and biophysical research communications.

[19]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  W. Chick.  Beta Cell Replication in Rat Pancreatic Monolayer Cultures: Effects of Glucose, Tolbutamide, Glucocorticoid, Growth Hormone and Glucagon , 1973, Diabetes.

[21]  E. Joslin,et al.  Joslin's Diabetes Mellitus , 1971 .